Contact this trialFirst, we need to learn more about you.
Janus Kinase Inhibitor
Brepocitinib for Dermatomyositis
Recruiting1 awardPhase 2
Scottsdale, Arizona
This trial will study the effects of a medication called brepocitinib on individuals with a skin condition called dermatomyositis. Participants will take brepocitinib for 12 weeks after
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service